穴位埋线治疗顽固性面瘫的有效性与安全性:系统评价与Meta分析
该系统评价与Meta分析纳入18项在中国开展的随机对照试验(共1881例顽固性面瘫患者),比较穴位埋线(AE)与手法针灸(MA)或电针(EA)的疗效与安全性。结果显示AE在总有效率、治愈率及面神经功能评分上多优于MA/EA,但与EA相比面神经功能评分及不良反应无显著差异;纳入研究证据质量普遍较低,安全性信息有限。
要点
- 穴位埋线治疗顽固性面瘫的总有效率和治愈率优于手法针灸和电针。
- 穴位埋线与电针在面神经功能评分及不良反应方面无显著差异。
- 纳入研究均在中国开展且证据质量低,安全性数据有限。
核心结论
- 多数纳入研究显示穴位埋线治疗顽固性面瘫较手法针灸或电针更有效。
- 但多数研究证据质量低,且均在中国开展,安全性信息有限。
研究设计与样本
- 系统评价与Meta分析,检索8个数据库至2024年2月,纳入18项随机对照试验共1881例患者。
- 两名评价者独立提取数据,使用RoB 2.0评估偏倚风险,RevMan V5.4进行Meta分析。
主要发现
- 与手法针灸相比,穴位埋线的总有效率RR=1.28(95%CI 1.13-1.44,P<0.0001)。
- 与手法针灸相比,穴位埋线的治愈率RR=1.81(95%CI 1.05-3.12,P=0.03)。
- 与手法针灸相比,穴位埋线的面神经功能评分SMD=1.57(95%CI 1.16-1.99,P<0.00001)。
- 与电针相比,穴位埋线的总有效率RR=1.16(95%CI 1.10-1.22,P<0.00001),治愈率RR=1.70(95%CI 1.46-1.98,P<0.00001)。
- 与电针相比,穴位埋线的面神经功能评分SMD=2.04(95%CI -1.25-5.32,P=0.22)及不良反应RR=1.16(95%CI 0.35-3.78,P=0.81)无显著差异。
临床怎么用
- 对于顽固性面瘫,可考虑穴位埋线作为改善总有效率和治愈率的治疗选择。
- 与电针相比,穴位埋线在面神经功能评分和不良反应方面未见显著优势,选择时需个体化权衡。
- 因证据质量低且安全性信息有限,临床应用应密切监测不良反应。
局限性
- 纳入研究多数证据质量低。
- 所有研究均在中国开展,存在地域局限性。
- 关于穴位埋线安全性的信息报告有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Limited systematic reviews have explored the impact of acupoint embedding (AE) therapy on intractable facial paralysis (IFP). This review presents the current evidence on the efficacy and safety of AE therapy in the treatment of IFP. METHODS: PubMed, Embase, Cochrane Library, Web of Science, Chinese Biomedical Literature Database, VIP Database for Chinese Technical Periodicals, China National Knowledge Infrastructure, and Wanfang databases were systematically searched from inception to February 2024 to identify randomized controlled trials (RCTs) without language restrictions. Data extraction and analysis were independently conducted by two reviewers. The Risk of Bias was assessed using the Risk of Bias tool (version 2.0), and a meta-analysis was performed using the RevMan software (V5.4). SETTING: Eighteen RCTs involving 1881 patients were included in the analysis. RESULTS: AE therapy demonstrated a higher total effective rate (relative risk [RR]: 1.28; 95 % confidence interval [CI]: 1.13-1.44; P < 0.0001), cure rate (RR: 1.81; 95 % CI: 1.05-3.12; P = 0.03), and facial nerve function score (standardized mean differences [SMD]: 1.57; 95 % CI: 1.16-1.99; P < 0.00001) compared to that of manual acupuncture. Additionally, AE therapy showed a higher total effective rate (RR: 1.16; 95 % CI: 1.10-1.22; P < 0.00001) and cure rate (RR: 1.70; 95 % CI: 1.46-1.98; P < 0.00001) in comparison to that of electroacupuncture. However, there were no significant differences in facial nerve function scores(SMD:2.04; 95 % CI: -1.25-5.32; P = 0.22) or adverse reactions(RR: 1.16; 95 % CI: 0.35-3.78; P = 0.81) between AE therapy and electroacupuncture therapy. Evidence supporting the efficacy and safety of AE treatment is also insufficient. CONCLUSION: Most of the included studies indicated that AE therapy was more effective than MA/EA therapy for IFP. However, the quality of evidence for the majority of these studies was low, and all were conducted in China, where limited information has been reported regarding the safety of AE therapy.
引用
- Guo X, Zai F, Tang X, et al. Effectiveness and safety of acupoint embedding therapy for treating intractable facial paralysis: A systematic review and meta-analysis. Complement Ther Med. 2025. PMID: 40081507. doi:10.1016/j.ctim.2025.103162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。